Use of Injectable Platelet Rich Fibrin in Lichen Planus

Status Completed

Clinical Trial Summary

Platelet Rich Fibrine (PRF), which promotes wound healing by supporting angiogenesis, immunity and epithelial proliferation phases. over a decade has since past since PRF was developed and many clinicians now point to the potential use of a liquid version of PRF. a liquid injectable-platelet-rich fibrin (i-PRF) was developed by modifying spin centrifugation forces. At lower centrifugation speeds and by utilizing non-glass centrifugation tubes, the fibrin coagulation could be slowed down at early time points thus generating an injectable PRF. Much like traditional PRF, i-PRF contains an increase in leukocyte number and is further able to stimulate growth factor release.

Lichen planus is a common chronic mucocutaneous inflammatory disorder which generally affect s middle aged adults. Therapeutic methods including topical and systemic corticosteroids for the treatment of oral lichen planus (OLP) are suggested. However, long

-term use of corticosteroids may be associated with local and systemic complications, and moreover, some patients may not be responsive.

The investigators aimed to apply a treatment of autogenous origin (including no foreign products), considering the side effects of our corticosteroids. The study was designed as a split mouth.

The investigators planned to administer I-PRF to one side and intralesional corticosteroid therapy to the other side at patients with bilateral atrophic / erosive oral lichen planus lesions

Clinical Trial Description

Lichen planus diagnosis will be made histopathologically. Intraoral photographs and measurements will be taken at the beginning of the treatment and 2 months after the treatment is finished. ;

Study Design

Related Conditions & MeSH terms

Lichen Planus

Clinical Trial Details

NCT number	NCT03265093
Study type	Interventional
Source	Bezmialem Vakif University
Contact
Status	Completed
Phase	N/A
Start date	May 3, 2017
Completion date	September 2, 2019

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06021405` - Koebner's Phenomenon in Psoriasis and Lichen Planus	N/A
Recruiting	`NCT03340155` - Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases	N/A
Completed	`NCT05787925` - Adjunctive Oral Systemic Vitamin E Therapy on Salivary Nitric Oxide Level in Patients With Erosive Oral Lichen Planus	N/A
Completed	`NCT03630198` - Pain Outcomes Following Intralesional Corticosteroid Injections	Phase 4
Completed	`NCT04952961` - Early Detection of Vulval CAncer Through Self-Examination (EDuCATE): Intervention Study	N/A
Recruiting	`NCT04697563` - Laser Therapy in Women With Lichenoid Disorders	N/A
Recruiting	`NCT06451744` - Cellular and Molecular Biomarkers in Patients With Lichen Planus	N/A
Completed	`NCT03858634` - A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases	Phase 2
Completed	`NCT02761122` - Implication of Human Papillomavirus (HPV) in Lichen Physiopathology in Human (HPVLichen)	N/A
Active, not recruiting	`NCT00691106` - A Multi-center Study to Evaluate the Safety of Etanercept in the Treatment of Lichen Planus	Phase 2
Terminated	`NCT05761158` - Study of the Characteristics of Pruritus in Patients With Frontal Fibrosing Alopecia or Lichen Planus Pilaris
Recruiting	`NCT02261662` - Off-Label Use of Ribavirin in Management of Mucocutaneous Extrahepatic Manifestations of HCV Infection	N/A
Not yet recruiting	`NCT04892381` - Assessment of PD-1 and PD-L1Tissue Expression Levels in Lichen Planus Patients: A Case-Control Study
Completed	`NCT05396261` - a Flexible Wound Dressing for the Management of Genital Skin Conditions	N/A
Recruiting	`NCT02532166` - Incidence of Esophageal Lichen Planus in Patients With Known Oral Lichen Planus	N/A
Recruiting	`NCT06327620` - Treatment Of Oral Lichen Planus	N/A
Completed	`NCT03796806` - Methods Validation Assessment for Study of Inflammatory Skin Disease
Completed	`NCT02850601` - Dexamethasone Solution for the Treatment of Oral Lichen Planus	Phase 2
Not yet recruiting	`NCT01041625` - Pilot Study of Apremilast (CC-10004) in the Treatment of Moderate to Severe Lichen Planus	Phase 2
Completed	`NCT00824889` - Exploratory Study of Natural Killer Cells in Human Skin	N/A